1107 related articles for article (PubMed ID: 19088061)
1. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
[TBL] [Abstract][Full Text] [Related]
2. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
3. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
4. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.
Matikainen S; Paananen A; Miettinen M; Kurimoto M; Timonen T; Julkunen I; Sareneva T
Eur J Immunol; 2001 Jul; 31(7):2236-45. PubMed ID: 11449378
[TBL] [Abstract][Full Text] [Related]
5. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
[TBL] [Abstract][Full Text] [Related]
6. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
8. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
9. Bovine splenic NK cells synthesize IFN-gamma in response to IL-12-containing supernatants from Babesia bovis-exposed monocyte cultures.
Goff WL; Storset AK; Johnson WC; Brown WC
Parasite Immunol; 2006 May; 28(5):221-8. PubMed ID: 16629708
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
Øren A; Husebø C; Iversen AC; Austgulen R
J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
[TBL] [Abstract][Full Text] [Related]
11. Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum.
McCall MB; Roestenberg M; Ploemen I; Teirlinck A; Hopman J; de Mast Q; Dolo A; Doumbo OK; Luty A; van der Ven AJ; Hermsen CC; Sauerwein RW
Eur J Immunol; 2010 Dec; 40(12):3472-7. PubMed ID: 21072880
[TBL] [Abstract][Full Text] [Related]
12. Innate IFN-gamma production by subsets of natural killer cells, natural killer T cells and gammadelta T cells in response to dying bacterial-infected macrophages.
Kubota K
Scand J Immunol; 2010 Mar; 71(3):199-209. PubMed ID: 20415785
[TBL] [Abstract][Full Text] [Related]
13. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells.
Motegi A; Kinoshita M; Sato K; Shinomiya N; Ono S; Nonoyama S; Hiraide H; Seki S
J Leukoc Biol; 2006 Mar; 79(3):463-72. PubMed ID: 16387840
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.
Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG
Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621
[TBL] [Abstract][Full Text] [Related]
15. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
Iho S; Yamamoto T; Takahashi T; Yamamoto S
J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
Ortaldo JR; Frey J; Takeshita T; Sugamura K
Eur Cytokine Netw; 1990; 1(1):27-34. PubMed ID: 2151685
[TBL] [Abstract][Full Text] [Related]
17. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells.
Gruenbacher G; Gander H; Nussbaumer O; Nussbaumer W; Rahm A; Thurnher M
Cancer Res; 2010 Dec; 70(23):9611-20. PubMed ID: 20947520
[TBL] [Abstract][Full Text] [Related]
18. Porcine T lymphocytes and NK cells--an update.
Gerner W; Käser T; Saalmüller A
Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production.
Micallef MJ; Ohtsuki T; Kohno K; Tanabe F; Ushio S; Namba M; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Fukuda S; Kurimoto M
Eur J Immunol; 1996 Jul; 26(7):1647-51. PubMed ID: 8766574
[TBL] [Abstract][Full Text] [Related]
20. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
Yu J; Wei M; Becknell B; Trotta R; Liu S; Boyd Z; Jaung MS; Blaser BW; Sun J; Benson DM; Mao H; Yokohama A; Bhatt D; Shen L; Davuluri R; Weinstein M; Marcucci G; Caligiuri MA
Immunity; 2006 May; 24(5):575-90. PubMed ID: 16713975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
